On January 5, several listed companies in Shanghai and Shenzhen issued announcements. The following is a summary of important announcements.
major events
Jiangsu Dagang Co.Ltd(002077) : it is proposed to continue to sell Jiangsu Cnano Technology Co.Ltd(688116) shares
Jiangsu Dagang Co.Ltd(002077) (002077) announced on January 5 that up to now, the company has sold 738700 Jiangsu Cnano Technology Co.Ltd(688116) shares, accounting for 0.32% of the total share capital of Jiangsu Cnano Technology Co.Ltd(688116) , and the company currently holds 700000 Jiangsu Cnano Technology Co.Ltd(688116) shares, accounting for 0.30% of the total share capital of Jiangsu Cnano Technology Co.Ltd(688116) . The company plans to continue to sell the remaining Jiangsu Cnano Technology Co.Ltd(688116) shares according to the situation of the securities market until the sale is completed.
Anhui Jinchun Nonwoven Co.Ltd(300877) : the ES composite staple fiber project with an annual output of 15000 tons has been completed
Anhui Jinchun Nonwoven Co.Ltd(300877) (300877) announced on January 5 that at present, the construction of ES composite staple fiber project with an annual output of 15000 tons has been completed and entered the commissioning stage. The company will optimize the device and process parameters according to the commissioning and operation, so as to achieve the production and standard of the project as soon as possible. Es composite staple fiber is the raw material for the production of hot air non-woven fabric. The completion and operation of the project with an annual output of 15000 tons of ES composite staple fiber will help to reduce the impact of market raw material price fluctuation on products.
Cts International Logistics Corporation Limited(603128) : it is proposed to transfer 100% equity and related creditor’s rights of Foshan Huamao
Cts International Logistics Corporation Limited(603128) (603128) announced on January 5 that it is planned to transfer 100% of the equity and related creditor’s rights of Foshan port CTS China Trade International Logistics Co., Ltd. by listing at the base price of 57.452 million yuan with reference to the assessed value.
Hangzhou Shenhao Technology Co.Ltd(300853) : the company was recognized as the Provincial Key Laboratory in 2022
Hangzhou Shenhao Technology Co.Ltd(300853) (300853) announced on January 5 that according to the relevant notice, the company successfully passed the audit, review and publicity of Zhejiang Provincial Department of science and technology, was recognized as the “Provincial Key Laboratory in 2022”, and the laboratory name was “Zhejiang intelligent operation and maintenance Siasun Robot&Automation Co.Ltd(300024) ” key Laboratory (co construction unit: Zhejiang University).
Dlg Exhibitions & Events Corporation Limited(600826) : if some houses in Huangpu District are included in the collection scope, they will receive a compensation of 45116900 yuan
Dlg Exhibitions & Events Corporation Limited(600826) (600826) announced on January 5 that the company’s house located at No. 107, Huqiu Road, Huangpu District was included in the scope of expropriation according to the old urban area reconstruction project of phase II (enterprises and institutions) of Bund source, Huangpu District. According to the compensation agreement, the company expects to obtain a total compensation of 45.1169 million yuan for the collection of the house, which shall be subject to the compensation recorded in the settlement sheet.
Jingjin Environmental Protection Co.Ltd(603279) : it is proposed to change the securities abbreviation to “Jingjin equipment”
Jingjin Environmental Protection Co.Ltd(603279) (603279) announced on January 5 that the company plans to apply to Shanghai Stock Exchange to change the securities abbreviation from ” Jingjin Environmental Protection Co.Ltd(603279) ” to “Jingjin equipment”.
Shenzhen Jianyi Decoration Group Co.Ltd(002789) : the controlling shareholder intends to transfer 7.04% of the company’s shares
Shenzhen Jianyi Decoration Group Co.Ltd(002789) (002789) announced on January 5 that Zhengfang group, the controlling shareholder of the company, plans to transfer 11.24 million shares of the company held by director Liu Haiyun (accounting for 7.04% of the total share capital of the company) through agreement transfer. The transfer price is 14.77 yuan / share, and the transfer price is 166 million yuan. After the equity change is completed, Zhengfang group will become the largest shareholder with the largest shareholding ratio and voting right ratio of the company, and the shareholding ratio will exceed more than 5% of that held by Liu Haiyun, so as to further ensure the stability of the controlling right of the company.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) : Paracetamol hydrocodone tablets obtained FDA approval No.
Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) (600521) announced on January 5 that recently, the company’s brief application for a new drug of paracetamol hydrocodone tablets declared to the FDA has been approved. The approval number of paracetamol hydrocodone tablets by FDA indicates that the company has the qualification to sell the product in the U.S. market. Paracetamol hydrocodone tablets are mainly used to relieve moderate to severe pain.
Guangdong Huiyun Titanium Industry Co.Ltd(300891) : the technical transformation project with an annual output of 30000 tons of anatase titanium dioxide (phase II) has been accepted
Guangdong Huiyun Titanium Industry Co.Ltd(300891) (300891) announced on January 5 that the company’s own funds have invested in the construction of the “technical transformation project with an annual output of 30000 tons of anatase titanium dioxide (phase II)”, which has recently completed the independent acceptance and publicity of environmental protection. After the project is completed, the company’s anatase production line will form a production capacity of 30000 tons / year of anatase titanium dioxide.
Jiangsu Hengrui Medicine Co.Ltd(600276) : the company and its subsidiaries obtained drug clinical trial approval
Jiangsu Hengrui Medicine Co.Ltd(600276) (600276) it was announced on January 5 that the company and its subsidiary Suzhou shengdia biomedical Co., Ltd. received the notice of approval for clinical trial of apatinib mesylate tablets and shr-1701 injection approved and issued by the State Food and drug administration, and will carry out clinical trial in the near future.
Harbin Medisan Pharmaceutical Co.Ltd(002900) : Omeprazole Sodium for injection passed the consistency evaluation
Harbin Medisan Pharmaceutical Co.Ltd(002900) (002900) announced on January 5 that the company recently received the notice of approval for supplementary drug application approved and issued by the State Food and drug administration. The company’s product omeprazole sodium for injection passed the consistency evaluation of generic drug quality and efficacy. Omeprazole sodium for injection is mainly suitable for peptic ulcer bleeding, anastomotic ulcer bleeding, etc.
National Silicon Industry Group Co.Ltd(688126) : recently received government subsidies totaling 14.1175 million yuan
National Silicon Industry Group Co.Ltd(688126) (688126) announced on January 5 that from October 27, 2021 to December 31, 2021, the company and its holding subsidiaries have received various income related government subsidies totaling 14.1175 million yuan. The above government subsidies obtained by the company are revenue related government subsidies, which are expected to have a positive impact on the profits of 2021.
Inner Mongolia Pingzhuang Energy Resources Co.Ltd(000780) : an application for termination of listing has been submitted to Shenzhen Stock Exchange
Inner Mongolia Pingzhuang Energy Resources Co.Ltd(000780) (000780) announced on January 5 that the company is the merged party, which belongs to the situation that “the company no longer has independent subject qualification and is cancelled due to new merger or absorption merger” stipulated in Item (4) of paragraph 1 of article 14.8.1 of the stock listing rules of Shenzhen Stock exchange (revised in December 2020), in accordance with the relevant provisions of Shenzhen Stock Exchange, The company has submitted application materials for active termination of listing to Shenzhen Stock Exchange.
Zhejiang Tianyu Pharmaceutical Co.Ltd(300702) : proline hengglitazin API passed CDE approval
Zhejiang Tianyu Pharmaceutical Co.Ltd(300702) (300702) announced on January 5 that the company’s proline hengglinet API passed the technical review of the drug evaluation center of the State Food and Drug Administration (hereinafter referred to as “CDE”). Proline hengglitazin is a sodium glucose cotransporter 2 (SGLT2) inhibitor. By inhibiting SGLT2, it reduces the reabsorption of glucose filtered by renal tubules and increases urinary glucose excretion. According to the announcement on CDE website, at present, only one company has passed the CDE technical review of proline hengglitazin API.
Dongguan Kingsun Optoelectronic Co.Ltd(002638) : “double reduction” price limit measures will have a significant adverse impact on the profitability of Longwen education
Dongguan Kingsun Optoelectronic Co.Ltd(002638) (002638) announced on January 5 that since Longwen education, a wholly-owned subsidiary, accounts for more than 50% of the company’s operating revenue and profits, the policy changes in the education and training industry will have a great impact on Longwen education and the company’s overall operation, and the “double reduction” price limit measures will have a significant adverse impact on the profitability of Longwen education. In addition, as of September 30, 2021, the recoverable amount of goodwill formed by the company’s acquisition of Longwen education is RMB 194 million, and the remaining goodwill is still subject to partial or full impairment in the future.
Dizhe medicine: dzd8586 obtained the drug clinical trial approval notice of the State Food and Drug Administration
Dizhe Pharmaceutical (688192) announced on January 5 that recently, the company received the notice of approval of drug clinical trial on dzd8586 approved and issued by the State Drug Administration and agreed to approve the clinical trial of recurrent and refractory B-cell non-Hodgkin lymphoma (NHL) in China. The company will start the phase I clinical trial of recurrent refractory B-cell non-Hodgkin lymphoma (NHL) in China as soon as possible.
Tonghua Dongbao Pharmaceutical Co.Ltd(600867) : it is proposed to transfer Xiamen Amoytop Biotech Co.Ltd(688278) 5% shares with an agreement of RMB 460 million
Tonghua Dongbao Pharmaceutical Co.Ltd(600867) (600867) announced on January 5 that the company plans to transfer Xiamen Amoytop Biotech Co.Ltd(688278) 5.0025% shares to Qingdao Dingxing qiguang medical industry investment fund by agreement, with a transfer price of 22.608 yuan / share and a transfer price of 460 million yuan.
Ligao Foods Co.Ltd(300973) : increase the price of some products by 3% – 8%
Ligao Foods Co.Ltd(300973) (300973) announced on January 5 that after study and careful consideration, the company decided to adjust the ex factory prices of some main frozen baked foods and baked raw materials by 3% – 8%. The adjusted prices will be implemented according to the price adjustment notice of each product from January 4, 2022.
Phichem Corporation(300398) : the company does not supply Pfizer with pharmaceutical intermediate products
Phichem Corporation(300398) (300398) disclosed the announcement of stock trading changes on January 5. After careful internal verification, the company did not sign any purchase and sales contract with Pfizer and did not supply pharmaceutical intermediate products to Pfizer. The company’s main business is the research, production and sales of screen display materials, semiconductor materials and UV curing materials applicable to the high-tech manufacturing field. The revenue of pharmaceutical intermediate business accounts for a relatively small proportion and has little impact on the company’s overall performance.
Sundy Land Investment Co.Ltd(600077) : at present, there are no personnel, technology, equipment and resources to develop the lithium industry
Sundy Land Investment Co.Ltd(600077) (600077) announced the change on January 5. At present, there are no personnel, technology, equipment and resources for the development of lithium industry, and no relevant investment agreement has been signed. Lithium industry is a resource intensive and talent shortage industry, which requires high investment cost and certain uncertainty in valuation. Its operation may be affected by industry environment, macro-economy, market changes and other factors, with great uncertainty. The company’s main business is still real estate operation and sales, which has not changed.
Aba Chemicals Corporation(300261) : completion of suspension verification and resumption of stock trading
Aba Chemicals Corporation(300261) (300261) announced on January 5 that in view of the completion of relevant self inspection, the trading of the company’s shares will resume from the opening of the market on January 6. As of the reply date of the letter of concern, the company has not signed any cooperation agreement with Pfizer, has no cooperative relationship with Pfizer, and has not supplied carlon anhydride and its derivatives to Pfizer. The customers of the company’s carbonic anhydride and its derivatives are mainly Chinese customers and Indian customers. It is uncertain whether the company’s carbonic anhydride and its derivatives are indirectly supplied to Pfizer. The company’s sales revenue of carbonic anhydride and its derivatives accounted for a relatively small proportion in 2021, which is not expected to have a significant impact on the company’s performance in 2021.
Chongqing Wanli New Energy Co.Ltd(600847) : the proposed acquisition of shares controlling Teri battery was suspended
Chongqing Wanli New Energy Co.Ltd(600847) (600847) announced on January 5 that the company is planning to acquire the control right of Chongqing Teri battery materials Co., Ltd. (hereinafter referred to as Teri battery) through major asset replacement and share issuance, and raise supporting funds. This transaction constitutes a major asset restructuring and a related party transaction. The trading of the company’s shares has been suspended since the opening of the market on January 6.
performance express
Square Technology Group Co.Ltd(603339) : the net profit in 2021 is expected to increase by 58% – 71%
Square Technology Group Co.Ltd(603339) (603339) announced on January 5 that it is expected to realize a net profit of 168-182 million yuan in 2021, with a year-on-year increase of 58.24% – 71.4%. At present, the company has sufficient orders on hand, the sales scale has increased steadily, and the operation continues to improve.
Acrel Co.Ltd(300286) : the net profit in 2021 will increase by about 30% – 55% year-on-year
Acrel Co.Ltd(300286) (300286) announced on January 5 that the company’s pre profit in 2021 was 158-188 million yuan, a year-on-year increase of about 30% – 55%. During the year, the introduction of a series of policies such as double carbon, double control, power restriction and increasing electricity price for high-energy consuming enterprises promoted the market’s attention to energy efficiency management and stimulated the market’s attention and demand in the field of microgrid.
Suzhou Nanomicro Technology Co.Ltd(688690) : the net profit in 2021 is expected to increase by 131% – 155%
Suzhou Nanomicro Technology Co.Ltd(688690) (688690) announced on January 5 that it is expected to achieve a net profit of 168-185 million yuan in 2021, with a year-on-year increase of 131.11% – 154.5%. In 2021, the company strengthened the demand docking and application technical services of key customers, and realized the application of many new projects such as antibody, recombinant protein, vaccine, insulin and contrast agent, especially the number of projects in various stages such as R & D, pilot test and scale-up production of monoclonal antibody biological drugs increased significantly, driving the company’s affinity chromatography media The sales of ion exchange chromatography media and other products increased significantly over the previous year.
Nanjing Yunhai Special Metals Co.Ltd(002182) : the net profit in 2021 is expected to increase by 105% – 138% year-on-year
Nanjing Yunhai Special Metals Co.Ltd(002182) (002182) announced on January 5 that the company’s pre profit in 2021 was 500 million yuan – 580 million yuan, a year-on-year increase of 105.13% – 137.95%. The increase in performance was mainly due to the increase in product prices, gross profit margin and sales volume.
Zhejiang Wazam New Materials Co.Ltd(603186) : the net profit in 2021 will increase by 88% to 104% year-on-year
Zhejiang Wazam New Materials Co.Ltd(603186) (603186) announced on January 5 that the net profit attributable to the shareholders of the listed company is expected to be 235 million yuan to 255 million yuan in 2021, an increase of 88% to 104% year-on-year compared with the same period of the previous year. During the reporting period, the strong demand of the industry and the booming production and marketing promoted the profitability of the company; At the same time, the company continues to upgrade its product structure and enhance its competitiveness.
Inner Mongoliayuan Xing Energy Company Limited(000683) : the net profit in 2021 is expected to increase by 7022% – 7316%
Inner Mongoliayuan Xing Energy Company Limited(000683) (000683) announced on January 5 that the company’s pre profit in 2021 was 4.85 billion yuan – 5.05 billion yuan, a year-on-year increase of 7022.30% – 7316.00%. During the reporting period, the company’s soda ash and urea production units operated efficiently, and the average sales price of leading products increased significantly over the previous year; The contribution of the coal sector to the company’s profits increased significantly over the previous year.
Telling Telecommunication Holding Co.Ltd(000829) : the net profit in 2021 will increase by 7.47% – 23.59%
Telling Telecommunication Holding Co.Ltd(000829) (000829) announced on January 5 that the company’s pre profit in 2021 was 200 million yuan – 230 million yuan, with a year-on-year increase of 7.47% – 23.59%. During the reporting period, the sales capacity of the company’s mobile phone business continued to improve, and the sales performance of some agent brands increased steadily. At the same time, the company’s new business model expanded steadily, expanding new categories such as e-cigarettes and 3C intelligent terminals, and the overall profitability increased significantly compared with the same period last year.
Zhejiang Shuanghuan Driveline Co.Ltd(002472) : the net profit in 2021 is expected to increase by more than 5 times year-on-year
Zhejiang Shuanghuan Driveline Co.Ltd(002472) (002472) announced on January 5 that the company’s pre profit in 2021 was 316 million yuan – 336 million yuan, with a year-on-year increase of 516.82% – 555.85%. During the reporting period, relying on the acceleration of domestic substitution for import in the field of gear manufacturing and the trend of outsourcing gear parts to professional manufacturers by main engine manufacturers, many high-quality projects of the company entered the rapid climbing stage, and the capacity of strategic layout was gradually released; The company has seized the market opportunity in the field of new energy vehicle drive system gears and promoted the improvement of industry concentration.
Jiangsu Yida Chemical Co.Ltd(300721) : the expected profit in 2021 is 120 million yuan – 150 million yuan, and the loss is reversed year-on-year
Jiangsu Yida Chemical Co.Ltd(300721) (300721) announced on January 5 that in 2021, the company’s pre profit was 120 million yuan – 150 million yuan, reversing losses year-on-year. In 2021, affected by the factors of better epidemic control in China and higher prosperity of China’s chemical industry, the prices of the company’s alcohol ether and alcohol ether ester series products were at a high level, and the company’s sales revenue increased significantly compared with the same period last year, making the performance turn loss into profit and increase greatly in 2021.
Shenyang Jinshan Energy Co.Ltd(600396) : the cost of power generation and heating is upside down, and the pre loss in 2021 is 1.8 billion to 2.038 billion
Shenyang Jinshan Energy Co.Ltd(600396) (600396) announced on January 5 that the company expects the net profit attributable to shareholders of Listed Companies in 2021 to be -1.8 billion yuan to -2.038 billion yuan. Affected by external factors, the company’s coal price increased significantly year-on-year in the reporting period, and the company’s power generation and heating costs were upside down.
Shandong Sinocera Functional Material Co.Ltd(300285) : the net profit in 2021 will increase by 36% – 43% year-on-year
Shandong Sinocera Functional Material Co.Ltd(300285) (300285) announced on January 5 that the company’s pre profit in 2021 was 784-824 million yuan, a year-on-year increase of 36.55% – 43.52%. During the reporting period, the epidemic situation in China was effectively controlled, market demand gradually recovered, various businesses of the company were steadily promoted, and the revenue and net profit increased steadily compared with the same period of last year. It is estimated that the impact of non recurring profits and losses on net profit during the reporting period is about 98.6 million yuan – 103 million yuan, mainly government subsidies and financial management income.
Tes Touch Embedded Solutions (Xiamen) Co.Ltd(003019) : the net profit in 2021 increased by 34.43% year-on-year
Tes Touch Embedded Solutions (Xiamen) Co.Ltd(003019) (003019) released the performance forecast on January 5. It is estimated that the net profit attributable to the parent company will be 149 million yuan in 2021, with a year-on-year increase of 34.43%. During the reporting period, the micro touch brand acquired by the company achieved remarkable operational results, and achieved rapid growth in revenue by integrating the company’s product strategy and micro touch customer resources; This year, the company has newly opened up the business of sports and fitness projects, further expanded the company’s product application field, and brought new business growth points to the company.
Allwinnertech Technology Co.Ltd(300458) : the net profit in 2021 is expected to increase by 125% – 164%
Allwinnertech Technology Co.Ltd(300458) (300458) announced on January 5 that it is expected to make a profit of 460-540 million yuan in 2021, with a year-on-year increase of 124.66% – 163.73%. During the reporting period, the growth of operating revenue and gross profit margin of intelligent hardware, intelligent vehicle and codec products promoted the growth of net profit, and the income from changes in fair value increased the net profit by about 81 million yuan.
Yantai Zhenghai Bio-Tech Co.Ltd(300653) : the net profit in 2021 will increase by 30% – 50% year-on-year
Yantai Zhenghai Bio-Tech Co.Ltd(300653) (300653) announced on January 5 that it is expected to realize a net profit of 154-178 million yuan attributable to shareholders of the listed company from January to December 2021, with a year-on-year increase of 30% – 50%. During the reporting period, the contribution of non recurring profit and loss to the net profit attributable to the shareholders of the listed company is expected to be about 7.6965 million yuan. The items of non recurring profit and loss are mainly various government subsidies received.
Zhongjin Irradiation Incorporated Company(300962) : the net profit in 2021 will increase by 34% – 60% year-on-year
Zhongjin Irradiation Incorporated Company(300962) (300962) announced on January 5 that the company’s pre profit in 2021 was about 82.4613 million yuan – 98.4613 million yuan, a year-on-year increase of 34% – 60%. In 2021, the company will accelerate market development, vigorously expand new technology applications and new application fields, strictly control costs and expenses, and further improve its core competitiveness and industry influence. The company expects that the annual performance will increase significantly compared with the same period last year.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) : in 2021, the pre profit is 330 million yuan to 390 million yuan, and the loss is reversed year-on-year
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) (002317) announced on January 5 that in 2021, the company’s pre profit was 330 million yuan to 390 million yuan, reversing losses year-on-year. During the reporting period, the net profit attributable to the shareholders of the listed company turned from loss to profit compared with the same period of the previous year, mainly due to the loss caused by the impairment of goodwill.
Jiangsu Eastern Shenghong Co.Ltd(000301) : the net profit in 2021 is expected to increase by 435% – 552%
Jiangsu Eastern Shenghong Co.Ltd(000301) (000301) announced on January 5 that the company’s pre profit in 2021 was 4.1-5 billion yuan, an increase of 435% – 552.44% over the same period of the previous year (after retroactive adjustment). During the reporting period, the demand of the chemical industry recovered, superimposed on the upward impact of crude oil price, the industry entered a recovery cycle and the prosperity increased. The production capacity of EVA photovoltaic resin produced by sierbang was stable at more than 200000 tons / year. The 200000 tons / year differential functional chemical fiber project of ganghong fiber and the 60000 tons / year pet regenerated fiber project of China perch technology were completed and put into operation in the second half of 2020, increasing the profit contribution year-on-year.
Col Digital Publishing Group Co.Ltd(300364) : the net profit in 2021 is expected to increase by 84% – 125% year-on-year
Col Digital Publishing Group Co.Ltd(300364) (300364) announced on January 5 that the company’s pre profit in 2021 was 90 million yuan – 110 million yuan, a year-on-year increase of 84% – 125%. The performance growth was mainly due to the growth of the company’s “literature +” business income, resulting in a significant increase in net profit over the same period of last year.
Guangdong Biolight Meditech Co.Ltd(300246) : the net profit in 2021 is expected to decrease by 77.47% to 82.67%
Guangdong Biolight Meditech Co.Ltd(300246) (300246) announced on January 5 that the company’s pre profit in 2021 was 60-78 million yuan, a year-on-year decrease of 77.47% to 82.67%. During the reporting period, due to the impact of the epidemic, the income of the company’s health monitoring products decreased significantly compared with that in 2020; The company vigorously established the marketing team and marketing network of dialyzer and dialysis equipment, which increased the relevant sales expenses; The company increased the development of high-end equipment, and the relevant R & D expenses increased significantly; The sharp rise in the purchase price of chips in raw materials has led to a significant increase in product costs.
major investment
Jiangsu Xiehe Electronic Co.Ltd(605258) : it is proposed to participate in a joint venture to invest in the construction of hydrogen fuel cell proton exchange membrane project
Jiangsu Xiehe Electronic Co.Ltd(605258) (605258) announced on January 5 that the company plans to jointly initiate the establishment of a joint venture “Jiangsu yuanhydrogen New Energy Technology Co., Ltd.” with Pan Asian Microvent Tech (Jiangsu) Corporation(688386) , Jiangsu Tuobang Investment Co., Ltd. and other 21 institutions and individuals to invest in the construction of hydrogen fuel cell proton exchange membrane project. The registered capital of the joint venture is 400 million yuan, of which Jiangsu Xiehe Electronic Co.Ltd(605258) contributes 5 million yuan, accounting for 1.25% of the total share capital of the joint venture.
Zhejiang Weiming Environment Protection Co.Ltd(603568) : it is proposed to invest no more than RMB 1.739 billion in the construction of high nickel matte project
Zhejiang Weiming Environment Protection Co.Ltd(603568) (603568) announced on January 5 that in November 2021, the controlling shareholder of the company, Weiming Group Co., Ltd. and indigo company signed the strategic cooperation framework agreement to jointly plan, invest, develop and construct the 40000 ton high matte nickel smelting project of laterite nickel ore in Indonesia. On January 5, the board of directors approved the company to invest in high nickel matte projects with its own funds and bank loans of no more than RMB 1.739 billion.
Jinyuan Ep Co.Ltd(000546) : the subsidiary plans to invest 800 million yuan in the construction of 8000 CuO Salt Lake 10000 ton lithium salt project
Jinyuan Ep Co.Ltd(000546) (000546) it was announced on January 5 that Liyuan mining, the holding subsidiary of the company, plans to invest 800 million yuan to build the “8000 CuO Salt Lake 10000 ton lithium salt project” in Ali, Tibet. The construction time of the project is from December 2021 to December 2022.
Shenzhen Dynanonic Co.Ltd(300769) : it is proposed to invest about 7.5 billion yuan to build a new phosphate cathode material production base project
Shenzhen Dynanonic Co.Ltd(300769) (300769) announced on January 5 that it is planned to build a “production base project of new phosphate cathode materials with an annual output of 330000 tons” in Qujing Economic and Technological Development Zone, with a total investment of about 7.5 billion yuan.
refinancing
Brightgene Bio-Medical Technology Co.Ltd(688166) : 205800 successful results of convertible bonds
Brightgene Bio-Medical Technology Co.Ltd(688166) (688166) disclosed the online winning results of convertible bonds on January 5. There are 205815 winning numbers in total, and each winning number can only subscribe one hand (1000 yuan) of Borui convertible bonds.
Shenzhen Farben Information Technology Co.Ltd(300925) : the proposed issuance of convertible bonds will raise no more than 601 million yuan
Shenzhen Farben Information Technology Co.Ltd(300925) (300925) announced on January 5 that the company plans to issue convertible corporate bonds to unspecified objects, and the total funds raised will not exceed 601 million yuan. After deducting the issuance expenses, the company plans to invest in the expansion project of regional comprehensive delivery center, the upgrading project of digital operation comprehensive management platform, the R & D project of industrial digital intelligent platform and supplementary working capital. In addition, Xia Haiyan, the shareholder of the company, plans to reduce his shares by no more than 3%.
increase and decrease
Shenzhen Sinexcel Electric Co.Ltd(300693) : shareholders intend to reduce their total holdings of no more than 7.37% shares
Shenzhen Sinexcel Electric Co.Ltd(300693) (300693) announced on January 5 that shareholders Xiao Xueli and Sheng Jianming expected to reduce their total holdings of no more than 7.3748% of the company’s shares.
Beijing Jiayu Door Window And Curtain Wall Joint-Stock Co.Ltd(300117) : the controlling shareholder intends to reduce its shares by no more than 8%
Beijing Jiayu Door Windo
